Market Place
Sourcing Support
Pfizer Metsera Data, 2025 Earnings; FDA Eyes REGENXBIO
04 Feb 2026 //
BIOSPACE
With 200 JPM Meetings, Novo BD Head Seeks Out The Next Metsera
27 Jan 2026 //
FIERCE BIOTECH
Novo Pursues Strategic Move To Advance Metsera Treatment
16 Jan 2026 //
BIOSPACE
Pfizer Completes Acquisition Of Metsera
13 Nov 2025 //
BUSINESSWIRE
Novo Nordisk Maintains Offer To Acquire Metsera
08 Nov 2025 //
GLOBENEWSWIRE
Pfizer Responds To Delaware Chancery Court Ruling
05 Nov 2025 //
BUSINESS WIRE
Judge Denies Pfizer`s Bid To Block Novo`s Offer For Metsera
05 Nov 2025 //
FIERCE PHARMA
Novo Nordisk CEO `Feels` Danish Pharma Will Bag Metsera
05 Nov 2025 //
FIERCE BIOTECH
FTC Tells Novo That Metsera Offer May Violate US Merger Law
05 Nov 2025 //
FIERCE PHARMA
Novo Nordisk Submits Updated Proposal To Acquire Metsera
04 Nov 2025 //
GLOBENEWSWIRE
Metsera Acknowledges Superior Amended Proposal From Novo Nordisk
04 Nov 2025 //
PR NEWSWIRE
Metsera Issues Statement in Response to Litigation
03 Nov 2025 //
FIERCE BIOTECH
Pfizer Cleared By US FTC For Metsera Acquisition
31 Oct 2025 //
BUSINESSWIRE
Pfizer Sues Metsera, Directors, And Novo Nordisk Over Merger
31 Oct 2025 //
BUSINESSWIRE
Metsera Issues Statement in Response to Litigation
31 Oct 2025 //
PR NEWSWIRE
Novo`s CEO Doesn`T Seem To Mind Being Big Pharma`s Villian
31 Oct 2025 //
BIOSPACE
Pfizer Addresses Proposal For Metsera
30 Oct 2025 //
BUSINESSWIRE
Novo Nordisk Submits Proposal To Acquire Metsera
30 Oct 2025 //
GLOBENEWSWIRE
Metsera Receives Unsolicited Proposal From Novo Nordisk
30 Oct 2025 //
PR NEWSWIRE
Pfizer Beat Out Two Other Metsera Suitors For Takeover
07 Oct 2025 //
BIOSPACE
Metsera to Present at Upcoming September Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Metsera`s Q2 2025 Financial Results and Portfolio Progress
28 Jul 2025 //
GLOBENEWSWIRE
Metsera to Present at Goldman Sachs Healthcare Conference
10 Jun 2025 //
GLOBENEWSWIRE
Metsera to Present New Research at 85th ADA Scientific Sessions
05 Jun 2025 //
GLOBENEWSWIRE
Metsera Reports Q1 2025 Financial Results and Portfolio Progress
12 May 2025 //
GLOBENEWSWIRE
Metsera Reports 2024 Financial Results and Portfolio Progress
26 Mar 2025 //
GLOBENEWSWIRE
CenExel Supports Metsera’s Ph 2 Success Of MET-097 In Obesity & Diseases
27 Feb 2025 //
ACCESSWIRE
Metsera to Present at TD Cowen’s Health Care Conference
26 Feb 2025 //
GLOBENEWSWIRE
Metsera hits $2.7 bln valuation as shares surge 42% in Nasdaq debut
01 Feb 2025 //
REUTERS
Metsera targets up to $1.78 billion valuation in US IPO
28 Jan 2025 //
REUTERS
Weight-loss drug developer Metsera reveals wider loss in IPO
10 Jan 2025 //
REUTERS
Metsera Touts ‘Powerful’ Weight Loss Results
08 Jan 2025 //
BIOSPACE
Altasciences Supports Metsera in Obesity Clinical Trials
21 Nov 2024 //
BUSINESSWIRE
Amneal And Metsera Partner On Next-Gen Obesity Medicines
01 Oct 2024 //
BUSINESSWIRE
Metsera GLP-1 data slice reveals 7.5% weight loss at 36 days
24 Sep 2024 //
FIERCE BIOTECH
